4.8 Review

Lyotropic liquid crystals for parenteral drug delivery

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 349, Issue -, Pages 533-549

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2022.06.062

Keywords

Liquid crystals; Parenteral delivery; In situ phase transition; Lyotropic liquid crystals; Microemulsion; Surfactant; Drug delivery

Funding

  1. L M College of pharmacy

Ask authors/readers for more resources

The development of novel long-acting parenteral formulations based on lipid-based liquid crystals has been encouraged by the need for long-term treatments of chronic diseases. These liquid crystal systems, formed by amphiphilic molecules, spontaneously form liquid crystal nanoparticles in aqueous tissue environments, creating an in-situ long-acting sustained-release depot for extended treatment efficacy. This manuscript summarizes the different types of liquid crystals, recent formulation advancements, analytical evaluation, and therapeutic application of lyotropic liquid crystals in the field of parenteral sustained release drug delivery.
The necessity for long-term treatments of chronic diseases has encouraged the development of novel long-acting parenteral formulations intending to improve drug pharmacokinetics and therapeutic efficacy. Lately, one of the novel approaches has been developed based on lipid-based liquid crystals. The lyotropic liquid crystal (LLC) systems consist of amphiphilic molecules and are formed in presence of solvents with the most common types being cubic, hexagonal and lamellar mesophases. LC injectables have been recently developed based on polar lipids that spontaneously form liquid crystal nanoparticles in aqueous tissue environments to create the in-situ long-acting sustained-release depot to provide treatment efficacy over extended periods. In this manuscript, we have consolidated and summarized the various type of liquid crystals, recent formulation advancements, analytical evaluation, and therapeutic application of lyotropic liquid crystals in the field of parenteral sustained release drug delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update

Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, Nirav Shah, Sachin Verma, Shrinivas Savale, Suma Ray

Summary: COVID-19 pandemic has caused widespread transmission and millions of deaths globally. Despite research efforts and clinical trials, a specific and 100% effective treatment for severe cases has yet to be found. This article focuses on the potential of convalescent plasma therapy as a treatment option for COVID-19.

PROCESS BIOCHEMISTRY (2023)

Review Immunology

Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

Vivek P. Chavda, Toshika Mishra, Suneetha Vuppu

Summary: The zoonotic SARS-CoV-2 virus undergoes evolution, adaptation, and selection to develop variants that result in the pandemic. The spike protein, required for binding to host cells, has a high propensity for mutations, generating numerous variants. Hybrid variants can also be produced through recombination of genomic sequences from two different lineages of the virus. Genome sequencing is the most accurate approach for identifying the hybrid variants, while immunological diagnostic assays provide insight into their pathogenesis and reactions.

VACCINES (2023)

Review Immunology

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management

Vivek P. Chavda, Pankti Balar, Dixa Vaghela, Hetvi K. Solanki, Akta Vaishnav, Vivek Hala, Lalitkumar Vora

Summary: Omicron variants have had a significant impact globally, with a high rate of transmissibility making their management difficult. There are multiple subtypes of omicron, including BA.1, BA.2, BA.3, BA.4, and BA.5. An additional omicron subvariant BF.7 has recently emerged in some parts of India. Further studies are needed to better understand the new variant and its implications.

VACCINES (2023)

Review Biochemistry & Molecular Biology

Propolis and Their Active Constituents for Chronic Diseases

Vivek P. Chavda, Amit Z. Chaudhari, Divya Teli, Pankti Balar, Lalitkumar Vora

Summary: Propolis is a chemically diverse substance produced by honeybees from plant resins, and has been used as a traditional remedy for various purposes. It has gained recognition in pharmaceutical and nutraceutical areas due to its diverse chemical composition and potential health benefits. Over 300 molecular structures have been discovered in propolis, and it has been found to have various pharmacological activities. Abundant research has been conducted to explore propolis as an alternative therapy for chronic diseases, and clinical trials have shown its potency in preventing and curing certain conditions.

BIOMEDICINES (2023)

Review Chemistry, Multidisciplinary

Exosome nanovesicles: A potential carrier for therapeutic delivery

Vivek P. Chavda, Anjali Pandya, Lalit Kumar, Nidhi Raval, Lalitkumar K. Vora, Sreeranjini Pulakkat, Vandana Patravale, Yanhong Duo, Ben Zhong Tang

Summary: This paragraph introduces the formation, structure, and function of exosomes, which play an important role in intercellular communication and are associated with health and disease. Recently, exosome-based nanotechnology has provided opportunities for the development of next-generation nanomedicines. This review summarizes the recent advances in exosome nanotechnology research, including classification, isolation and preparation, constitution, biological function, and nanobiomedical applications in disease treatment and diagnosis, and prospects for the future.

NANO TODAY (2023)

Review Pharmacology & Pharmacy

Nasal sprays for treating COVID-19: a scientific note

Vivek P. Chavda, Kajal P. Baviskar, Dixa A. Vaghela, Shilpa S. Raut, Anjali P. Bedse

Summary: Clinical management of COVID-19 is challenging, and vaccines are considered the first line of defense. Studies on immune response focus on innate responses and cell-mediated systemic immunity. Due to difficulties with conventional routes, alternative prophylaxis and therapy routes are needed. Nasal vaccines are under development and can be self-administered for prevention and therapeutic purposes. Nasal drug delivery offers advantages such as needle-free administration and no refrigeration requirement. This article discusses various aspects of nasal sprays for eliminating COVID-19.

PHARMACOLOGICAL REPORTS (2023)

Review Immunology

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

Vivek P. Chavda, Nidhi Raval, Soham Sheta, Lalitkumar K. Vora, Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky, Yavuz Nuri Ertas

Summary: The newly emerged SARS-CoV-2 is highly infectious and rapidly mutating, causing severe effects on various body organs. Multiple approaches, including medications and supportive devices, have been successfully used for the intervention of COVID-19. Hemadsorption devices are discussed in this report as part of supportive treatment for the cytokine storm associated with COVID-19.

FRONTIERS IN IMMUNOLOGY (2023)

Review Pharmacology & Pharmacy

Drug Delivery Strategies for Avobenzone: A Case Study of Photostabilization

Amol D. Gholap, Sadikali F. Sayyad, Navnath T. Hatvate, Vilas V. Dhumal, Sagar R. Pardeshi, Vivek P. Chavda, Lalitkumar K. Vora

Summary: Ongoing developments and research methods in drug technology and chemistry aim to enhance the effectiveness of drugs and protect their molecular integrity. Sunscreen application and UV filters are important for shielding against UV damage, however, avobenzone, a widely used UVA filter, is prone to photodegradation. Various strategies, such as encapsulation and antioxidants, have been explored to address this issue. This review aims to summarize recent literature on drug delivery strategies for the photostabilization of avobenzone, with the potential for industrial applications.

PHARMACEUTICS (2023)

Editorial Material Immunology

The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity

Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar

VACCINES (2023)

Review Immunology

Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants

Vivek P. Chavda, Disha D. Valu, Palak K. Parikh, Nikita Tiwari, Abu Sufiyan Chhipa, Somanshi Shukla, Snehal S. Patel, Pankti C. Balar, Ana Claudia Paiva-Santos, Vandana Patravale

Summary: Accurate identification at an early stage of infection is crucial for effective care, especially in the case of the COVID-19 pandemic caused by the SARS-CoV-2 virus. The primary diagnostic methods include RT-PCR molecular technique and immunodiagnostic procedures. However, due to the increasing demand for testing, inexperienced producers and laboratories have led to the potential for errors in test results. Point-of-care testing and smart diagnostic techniques based on AI-ML and nanotechnology are discussed as potential solutions for rapid and accurate detection of SARS-CoV-2.

VACCINES (2023)

Editorial Material Infectious Diseases

Langya henipavirus outbreak

Vivek P. Chavda, Vasso Apostolopoulos, Ranjit Sah

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)

Editorial Material Biotechnology & Applied Microbiology

Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination

Vivek P. Chavda, Vasso Apostolopoulos

NANOMEDICINE (2023)

Article Medicine, General & Internal

Phenytoin-induced dyskinesia: a case report

Kashvi C. Shah, Nishi S. Patel, Paritosh Vasani, Avinash Khadela, Vivek P. Chavda, Lalitkumar Vora

Summary: A 53-year-old Asian patient developed involuntary muscle movements, impaired speech, and generalized tremors after taking phenytoin, which were successfully reversed with prompt identification and treatment. This case provides valuable reference for the diagnosis and treatment prognosis of phenytoin-induced dyskinesia.

JOURNAL OF MEDICAL CASE REPORTS (2023)

Letter Critical Care Medicine

Tomato flu: misnomer for a common disease?

Vivek P. Chavda, Kaushika Patel, Harsh Mod, Vasso Apostolopoulos

LANCET RESPIRATORY MEDICINE (2023)

Review Oncology

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer

Avinash Khadela, Vivek P. P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. J. Pandya, Lalitkumar Vora

Summary: This literature aims to explore the characteristics of anti-androgens against luminal androgen receptor-specific triple-negative breast cancer and provides a concise report on the clinical profile of anti-androgens. This review summarizes the types of triple-negative cancer cells, along with a brief discussion of the involvement of androgen receptors in the luminal type. The paper describes the evidence obtained from clinical trials and presents conclusions to assist clinicians in developing optimal strategies for mitigating LAR-TNBC and providing better patient care.

CANCERS (2023)

Review Chemistry, Multidisciplinary

Polymer mechanochemistry in drug delivery: From controlled release to precise activation

Zhiyuan Shi, Yong Hu, Xin Li

Summary: Controlled drug delivery systems that can respond to mechanical force offer a unique solution for on-demand drug activation and release. Among various mechanical stimuli, ultrasound (US) has advantages in achieving spatiotemporally controlled drug release. Traditional US-triggered drug release relies on heat-induced phase transitions or chemical transformations, while the cutting-edge approach of Sonopharmacology leverages polymer mechanochemistry. The remaining challenges and potential future directions in this field are also discussed.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis

Lijie Zheng, Yuanzheng Chen, Xun Gu, Yingying Li, Hanqing Zhao, Wenjun Shao, Tao Ma, Chuanbin Wu, Qingqing Wang

Summary: In this study, a novel dosage form consisting of dissolving microneedles and an adhesive transdermal patch was developed for the treatment of rheumatoid arthritis. In vitro and in vivo experiments demonstrated that the combination of drugs delivered by this dosage form effectively reduced joint inflammation and damage.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides

Kyungjik Yang, Hwa Seung Han, Seung Hwan An, Kyung Hoon Park, Keonwook Nam, Shinha Hwang, Yuyeon Lee, Sung Yeon Cho, Taehyung Kim, Deokyeong Choe, Sang Won Kim, Wonkyu Yu, Hyunah Lee, Jiyong Park, Sangguan You, Dong- Gyu Jo, Ki Young Choi, Young Hoon Roh, Jae Hyung Park

Summary: This study developed CP-loaded CS microcapsules to enhance the oral bioavailability of CP through controlled gastrointestinal delivery. The optimized microcapsules exhibited desirable physicochemical properties, showed anti-photoaging effects via antioxidant activity, and achieved controlled release in the gastrointestinal tract. This research provides a simple and economical approach for enhancing the oral bioavailability of CP for customized bioactive compound administration.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema

Huiyang Li, Shuo Liu, Wenjin Dai, Bingmei Yao, Yong Zhou, Sujia Si, Hairong Yu, Riguang Zhao, Fang Jin, Liqun Jiang

Summary: Changes in bodily fluid pressures are crucial in diseases like high-altitude pulmonary edema (HAPE). Researchers have developed hydrostatic pressure-sensitive multivesicular liposomes (PSMVLs) that can release drugs in response to pressure changes, with potential applications in HAPE treatment. Animal experiments showed that this system provides better protection for lung tissues and respiratory function, reducing the occurrence of pulmonary edema.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia

Qian Hu, Hongbing Lan, Yinmei Tian, Xiaonan Li, Mengmeng Wang, Jiao Zhang, Yulin Yu, Wei Chen, Li Kong, Yuanyuan Guo, Zhiping Zhang

Summary: Coacervate droplets formed through liquid-liquid phase separation have potential as delivery vesicles for therapeutics. However, their lack of physiological stability and membranes are challenges. In this study, polylysine-polynucleotide complex coacervate droplets with favorable stability were formulated to concentrate molecules and nanoparticles. Phospholipid membranes were further coated on the droplets to create coacervate-based artificial protocells (ArtPC) with membrane-like structures. These biofunctional ArtPC effectively reduced blood uric acid levels and prevented renal injuries.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer

Xiaowei Wang, Hongwei Lu, Fang Luo, Dan Wang, Apeng Wang, Xuelei Wang, Wenkai Feng, Xiaobo Wang, Jiayi Su, Mingliang Liu, Guimin Xia

Summary: Four novel lipid-like GEM diesters were synthesized and encapsulated into liposomes to improve the antitumor efficacy of Gemcitabine. The liposomes loaded with dimyristoyl GEM (LipodmGEM) showed enhanced cellular uptake, improved inhibition of cell migration, and a greatly extended half-life compared to free Gemcitabine. LipodmGEM successfully enriched the drug in the tumor and exhibited excellent anticancer efficacy in vivo with negligible systemic toxicity.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment

Pengyu Li, Jieyi Pan, Yating Dong, Yingying Sun, Yalong Wang, Kang Liao, Yili Chen, Xin Deng, Shihui Yu, Haiyan Hu

Summary: Chronic pulmonary infection caused by Pseudomonas aeruginosa is a serious public health problem with high mortality rates. In this study, infection-microenvironment responsive nanoparticles were developed to eradicate biofilms and inhibit virulence. These nanoparticles showed promising results in treating chronic pulmonary infections.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Yajing Sun, Ze Lu, John A. Taylor, Jessie L. S. Au

Summary: A recent development in cancer chemotherapy is the use of cytotoxics to induce tumor-specific immune response through immunogenic cell death (ICD). This study describes a method that utilizes immunostaining and machine-learning to identify cells with ecto-CRT in intact 3-dimensional tissues. The method was successfully applied to study drug-induced ICD in human bladder cancer.

JOURNAL OF CONTROLLED RELEASE (2024)

Review Chemistry, Multidisciplinary

Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation

Rafat Ali, Shantanu Sen, Rohil Hameed, Aamir Nazir, Sandeep Verma

Summary: This review provides a focused overview of emerging strategies for delivering gasotransmitters in a controlled and sustained manner to reestablish neurophysiological homeostasis.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Multifunctional hydrogel for synergistic reoxygenation and chemo/ photothermal therapy in metastatic breast cancer recurrence and wound infection

Jing Chen, Xinyi Zhang, Jinshen Zhang, Zhaoxia Wang, Guilan Zhu, Ming Geng, Jinmiao Zhu, Yajun Chen, Wei Wang, Youcui Xu

Summary: In this study, a multifunctional responsive hydrogel system was developed for synergistic reoxygenation and chemo/photothermal therapy. The hydrogel system showed both therapeutic effects against metastatic breast cancer and wound infection, making it a promising strategy for treating and preventing tumor recurrence and associated wound infection.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: Inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation

Baoshan Huang, Na Zhang, Xinying Qiu, Rui Zeng, Shuimiao Wang, Mengxia Hua, Qing Li, Kaihui Nan, Sen Lin

Summary: This study revealed that robust ROS can oxidize mitochondrial DNA (ox-mtDNA) and cause its release into the cytosol, resulting in the activation of NLRP3 inflammasome. By using the mitochondria-targeted antioxidant SkQ1 and a novel mitochondria-targeted nanoparticle (SkQ1 NP), it was found that mitochondrial ROS scavenging could in situ inhibit DED-induced mtDNA oxidation and suppress NLRP3-mediated inflammation.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction

Wenqi Liu, Cheng Hu, Linyu Long, Shuyi He, Wen Zhang, Zhicun Wang, Li Yang, Yunbing Wang

Summary: Myocardial infarction is the leading cause of cardiovascular mortality, and current treatment methods have limitations. This study developed a smart carrier that can release different therapeutic substances for different pathological processes, effectively improving cardiac function, promoting cardiac repair, and preventing ventricular remodeling.

JOURNAL OF CONTROLLED RELEASE (2024)